FibroBiologics Closes Second $5MM Tranche of $25MM Financing
FibroBiologics, a clinical-stage biotechnology company, closed the second $5 million tranche of the previously announced standby equity purchase agreement with YA II PN, an investment fund managed by Yorkville Advisors Global.
Read moreDetails









